F9 and hepatocellular carcinoma: Of all the cancer cell lines analysed, the renal adenocarcinoma cell line (ACHN) was the only cell line to upregulate F9 with Palbo and Abema (Fig. 5D), while the human colorectal adenocarcinoma cell line (HT29) and the hepatocellular carcinoma cell (SNU-387) increased F9 mRNA expression only with Palbo (Fig. 5D).